Literature DB >> 22653211

Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders.

Charlotte Harrison.   

Abstract

Entities:  

Year:  2012        PMID： 22653211     DOI： 10.1038/nrd3761

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism.

Authors:  Jill L Silverman; Daniel G Smith; Stacey J Sukoff Rizzo; Michael N Karras; Sarah M Turner; Seda S Tolu; Dianne K Bryce; Deborah L Smith; Kari Fonseca; Robert H Ring; Jacqueline N Crawley
Journal:  Sci Transl Med       Date:  2012-04-25       Impact factor: 17.956

2.  Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

Authors:  Aubin Michalon; Michael Sidorov; Theresa M Ballard; Laurence Ozmen; Will Spooren; Joseph G Wettstein; Georg Jaeschke; Mark F Bear; Lothar Lindemann
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173
  2 in total
  3 in total

1.  Sensory integration in mouse insular cortex reflects GABA circuit maturation.

Authors:  Nadine Gogolla; Anne E Takesian; Guoping Feng; Michela Fagiolini; Takao K Hensch
Journal:  Neuron       Date:  2014-07-31       Impact factor: 17.173

2.  A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors:  Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal:  BMC Psychiatry       Date:  2013-07-25       Impact factor: 3.630

3.  Impairment of translation in neurons as a putative causative factor for autism.

Authors:  Eugenia Poliakov; Eugene V Koonin; Igor B Rogozin
Journal:  Biol Direct       Date:  2014-07-10       Impact factor: 4.540
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.